Demographics of patients receiving TPOXX for treatment of monkeypox

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Demographics of patients receiving TPOXX for treatment of monkeypox

September 22, 2022
By National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.

[PDF-1.63 MB]

English

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
Description:

Updated September 22, 2022

TPOXX (tecovirimat) use for treatment of monkeypox is authorized under Food and Drug Administration (FDA) regulations, and CDC holds an expanded access Investigational New Drug (EA-IND) protocol. The IND forms are required to be submitted to CDC. The demographics of patients prescribed TPOXX treatment are based on the patient intake forms CDC has received and abstracted. However, this number underestimates the number of patients who are receiving TPOXX treatment as healthcare providers can start treatment before submitting IND paperwork to CDC.
Subjects:

[+]

Antiviral Agents Drugs, Investigational Mpox (monkeypox) Poxviridae Infections/drug Therapy Smallpox/drug Therapy
Document Type:

Webpage
Name as Subject:

Tecovirimat ; Tecovirimat

Tecovirimat ; Tecovirimat Less -
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:c2df67e5490d116989a9e30be3e0cdb3e3497ced7f2a9663e105690cea67226c
Download URL:

https://stacks.cdc.gov/view/cdc/122165/cdc_122165_DS1.pdf
File Type:

demographics-TPOXX.html

htm

More +